BioStem Technologies, Inc. (BSEM)
OTCMKTS
· Delayed Price · Currency is USD
12.65
-0.17 (-1.36%)
Dec 27, 2024, 4:00 PM EST
BioStem Technologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2017 | FY 2016 | 2015 - 2011 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | 2015 - 2011 |
| Revenue | 210.49 | 16.69 | 6.88 | 4.34 | 0.31 | 0.61 | Upgrade
|
| Revenue Growth (YoY) | 3445.26% | 142.69% | 58.38% | 1284.88% | -48.38% | 300.71% | Upgrade
|
| Cost of Revenue | 10.84 | 1.26 | 0.88 | 1.47 | 0.15 | 0.39 | Upgrade
|
| Gross Profit | 199.65 | 15.42 | 5.99 | 2.87 | 0.16 | 0.21 | Upgrade
|
| Selling, General & Admin | 176.17 | 21.91 | 10.21 | 4.07 | 4.77 | 3.95 | Upgrade
|
| Research & Development | 0.81 | 0.34 | 0.22 | 0.12 | - | - | Upgrade
|
| Operating Expenses | 177.2 | 22.48 | 10.67 | 4.47 | 4.77 | 3.95 | Upgrade
|
| Operating Income | 22.45 | -7.06 | -4.68 | -1.61 | -4.6 | -3.73 | Upgrade
|
| Interest Expense | -0.76 | -0.7 | -0.47 | -0.53 | -0.03 | -0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.01 | -0 | 0 | 0.03 | -0.02 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | 21.69 | -7.76 | -5.15 | -2.1 | -4.66 | -3.77 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.03 | 0 | -0.04 | Upgrade
|
| Asset Writedown | - | - | - | - | -0.15 | -0.15 | Upgrade
|
| Legal Settlements | - | -0.72 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | -2.08 | 0.66 | - | - | Upgrade
|
| Pretax Income | 21.69 | -8.48 | -7.23 | -1.41 | -4.81 | -3.96 | Upgrade
|
| Earnings From Continuing Operations | 15.85 | -8.48 | -7.23 | -1.41 | -4.81 | -3.96 | Upgrade
|
| Minority Interest in Earnings | - | - | 0.04 | -0.03 | 0.02 | 0 | Upgrade
|
| Net Income | 15.85 | -8.48 | -7.19 | -1.45 | -4.79 | -3.96 | Upgrade
|
| Net Income to Common | 15.85 | -8.48 | -7.19 | -1.45 | -4.79 | -3.96 | Upgrade
|
| Shares Outstanding (Basic) | 16 | 14 | 11 | 12 | 5 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 19 | 14 | 11 | 12 | 5 | 4 | Upgrade
|
| Shares Change (YoY) | 47.46% | 20.18% | -2.40% | 130.37% | 43.86% | 203.00% | Upgrade
|
| EPS (Basic) | 0.98 | -0.62 | -0.63 | -0.12 | -0.94 | -1.12 | Upgrade
|
| EPS (Diluted) | 0.82 | -0.62 | -0.63 | -0.12 | -0.94 | -1.12 | Upgrade
|
| Free Cash Flow | 14.6 | -3.6 | 0.06 | -0.15 | -1.79 | -2.41 | Upgrade
|
| Free Cash Flow Per Share | 0.75 | -0.26 | 0.01 | -0.01 | -0.35 | -0.68 | Upgrade
|
| Gross Margin | 94.85% | 92.45% | 87.17% | 66.03% | 52.25% | 35.10% | Upgrade
|
| Operating Margin | 10.67% | -42.30% | -68.09% | -36.99% | -1468.50% | -614.77% | Upgrade
|
| Profit Margin | 7.53% | -50.84% | -104.62% | -33.30% | -1529.17% | -651.81% | Upgrade
|
| Free Cash Flow Margin | 6.94% | -21.60% | 0.87% | -3.51% | -572.41% | -397.04% | Upgrade
|
| EBITDA | 22.67 | -6.83 | -4.46 | -1.32 | -4.44 | -3.59 | Upgrade
|
| EBITDA Margin | 10.77% | -40.93% | -64.86% | -30.45% | - | - | Upgrade
|
| D&A For EBITDA | 0.22 | 0.23 | 0.22 | 0.28 | 0.16 | 0.15 | Upgrade
|
| EBIT | 22.45 | -7.06 | -4.68 | -1.61 | -4.6 | -3.73 | Upgrade
|
| EBIT Margin | 10.67% | -42.30% | -68.09% | -36.99% | - | - | Upgrade
|
| Advertising Expenses | - | 0.2 | 0.09 | 0.07 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.